The Department of Pharmaceutical Sciences is a recognized leader in the field of drug discovery and development.
With strengths in structure-based drug design our expertise in physical, computational, synthetic, and protein chemistry cuts across several centers of excellence in Computer Aided Drug Design, Nuclear Magnetic Resonance (NMR), X-Ray Crystallography, and Mass Spectrometry. Innovative research in complex biological systems, proteomics, metabolomics, pharmacogenomics, and therapeutic engineering seeks to develop targeted innovative medicines and devices to improve human health. Optimization of therapeutic dosing regimens is the goal of our concentrated efforts in pharmacokinetics, pharmacometrics and drug delivery, including nanotechnology. Interdisciplinary research in collaboration with the University of Maryland College Park School of Engineering is the primary focus of the Center for Nanomedicine.
Faculty Research Interests:
Through collaborative research faculty are advancing basic science and drug discovery in infectious disease, cancer, metabolic diseases such as diabetes and obesity, and neurodegenerative disease.
Spring Seminar Schedule:
Download this informational flyer for details about upcoming seminars hosted by the Department of Pharmaceutical Sciences.
PhD in Pharmaceutical Sciences
Graduate students, staff, and faculty pursue a wide range of pharmaceutical research, such as the underlying biology of disease, mechanisms of drug action, drug design, and drug product design and evaluation.
MS in Pharmaceutical Sciences (Pharmacometrics)
The objective of the Executive Master’s in Pharmacometrics is to allow current professionals to acquire skills and knowledge to plan, perform and interpret pharmacometric analyses with the goal of influencing key drug development, regulatory and therapeutic decisions.
MS in Regulatory Science
Launching in Fall 2013, the MS in Regulatory Science program addresses all major areas of drug product regulatory science, including chemistry, manufacturing, and controls (CMC); clinical research; and post-approval surveillance, as well as drug discovery.
Copyright © 2013 University of Maryland School of Pharmacy